<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig2-1759720X20912646" orientation="portrait" position="float">
 <label>Figure 2.</label>
 <caption>
  <p>Suggested algorithm for the management of HBVr in rheumatic diseases.</p>
  <p>*In certain cases, close monitoring without antiviral therapy may be chosen after appropriate consultation. See text for details.</p>
  <p>ALT, alanine aminotransferase; anti-HBc, antibody against Hepatitis B core antigen; anti-HBs, antibody against HBsAg; ETV, entecavir; HBsAg, hepatitis B surface antigen; HBV-DNA, HBV-deoxyribonucleic acid; HBVr, hepatitis B virus reactivation; TAF, tenofovir alafenamide; TDF, tenofovir disoproxil fumarate.</p>
 </caption>
 <graphic xlink:href="10.1177_1759720X20912646-fig2" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
